Results 201 to 210 of about 1,373,920 (341)

The renin-angiontensin system and the development of new antiglaucoma medications

open access: diamond, 2022
Aline Ruilowa de Pinho Coelho   +2 more
openalex   +1 more source

TREX1, a predator for treating MSI‐H tumors?

open access: yesMolecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya   +2 more
wiley   +1 more source

Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. [PDF]

open access: yesJ Gen Intern Med
Anderson TS   +6 more
europepmc   +1 more source

Inter-rater reliability of medication error classification in a voluntary patient safety incident reporting system HaiPro in Finland

open access: green, 2018
Anna-Riia Holmström   +5 more
openalex   +2 more sources

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Can nonclinicians classify medication discrepancies as accurately as clinical pharmacists? A validation study

open access: yesHealth Science Reports, 2022
Julianne E. Brady   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy